Aktieanalys

XVIVO Q3: A negative FX surprise despite excellent organic growth - Redeye

Redeye Publicerad: 24 Oct 11:57

XVIVO delivers a Q3 that aligns with our expectations but is below market expectations due to FX headwind. The increased disposable capacity contributed to 54% growth of Thoracic disposables (62% for the whole Thoracic business based on CER), the service offer is subject to improvements, and Abdominal disposables had a modest quarter at 13% organic growth. On the positive side, we note that machine sales are high, so we are suggesting additional support in the future. The organic growth (CER) was 41%, which is a positive surprise even if actual sales were below market expectations and the FX headwind was higher than expected at 6% vs the expected -2%.

Länk till analysen i sin helhet: https://www.redeye.se/research/1045613/xvivo-q3-a-negative-fx-surprise-despite-excellent-organic-growth?utm_source=finwire&utm_medium=RSS

Nyheter om Xvivo Perfusion

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!